View Single Post
Old 10-11-2016, 06:32 AM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 18,975
Ribociclib improves progression-free survival in advanced breast cancer

The addition of the CDK4/6 inhibitor ribociclib to letrozole therapy significantly improves progression-free survival in postmenopausal women with hormone receptor-positive advanced breast cancer...

More...
News is offline   Reply With Quote